尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Holuka Eugene Myron. Insider active across 2 companies, notably Citius Pharmaceuticals, Inc.. Aggregated, 4 filings have been recorded. Activity tracked since 13 March 2024. The latest transaction was disclosed on 19 September 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Holuka Eugene Myron is a declarant linked to CITIUS ONCOLOGY, INC. and Citius Pharmaceuticals, Inc., where he is a Director. The record shows 4 filings in total, and the sampled recent filings run from 2024-08-30 to 2025-12-22, with transaction nature listed as Attribution.